{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T03:57:36Z","timestamp":1770091056025,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01258","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:37:57Z","timestamp":1541133477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells"],"prefix":"10.3389","volume":"9","author":[{"given":"Kathrin","family":"Renner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Seilbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Kauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Ugele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Siska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Brummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Bruss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja-Maria","family":"Decking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Fante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Hammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Klobuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gottfried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.gene.2018.01.017","article-title":"Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line.","volume":"647","author":"Asik","year":"2018","journal-title":"Gene"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3109\/10428194.2013.781170","article-title":"Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.","volume":"54","author":"Chen","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","article-title":"A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML.","volume":"378","author":"DiNardo","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B5","year":"2018","journal-title":"Database."},{"key":"B6","doi-asserted-by":"publisher","first-page":"C1064","DOI":"10.1152\/ajpcell.00179.2001","article-title":"H( + )-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo.","volume":"282","author":"Emoto","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism.","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2017-12-820035","article-title":"Glutaminolysis is a metabolic dependency in FLT3(ITD) acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition.","volume":"131","author":"Gallipoli","year":"2018","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism.","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066987","article-title":"New aspects of an old drug\u2013diclofenac targets MYC and glucose metabolism in tumor cells.","volume":"8","author":"Gottfried","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence.","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbamcr.2013.10.015","article-title":"Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.","volume":"1843","author":"Hua","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbrc.2012.05.001","article-title":"Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK\/ERK signaling pathway.","volume":"422","author":"Huai","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/leu.2017.45","article-title":"ITD mutation in FLT3 tyrosine kinase promotes warburg effect and renders therapeutic sensitivity to glycolytic inhibition.","volume":"31","author":"Ju","year":"2017","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/1541-7786.MCR-13-0172","article-title":"Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.","volume":"11","author":"Liu","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"B16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-2952(98)00330-X","article-title":"Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart.","volume":"57","author":"Moreno-Sanchez","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/0008-5472.CAN-17-1166","article-title":"VEGFR2-mediated reprogramming of mitochondrial metabolism regulates the sensitivity of acute myeloid leukemia to chemotherapy.","volume":"78","author":"Nobrega-Pereira","year":"2018","journal-title":"Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.610","article-title":"Repurposing drugs in oncology (ReDO)-diclofenac as an anti-cancer agent.","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1182\/bloodadvances.2017009829","article-title":"The role of targeted therapy in the management of patients with AML.","volume":"1","author":"Perl","year":"2017","journal-title":"Blood Adv."},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MOH.0000000000000411","article-title":"The most novel of the novel agents for acute myeloid leukemia.","volume":"25","author":"Perl","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3596","article-title":"Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment.","volume":"20","author":"Pollak","year":"2014","journal-title":"Nat. Med."},{"key":"B22","first-page":"8813","article-title":"Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, eppendorf electrode, and redox scanning.","volume":"63","author":"Poptani","year":"2003","journal-title":"Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0360-4","article-title":"TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.","volume":"9","author":"Qian","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00248","article-title":"Metabolic hallmarks of tumor and immune cells in the tumor microenvironment.","volume":"8","author":"Renner","year":"2017","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.dmpk.2016.03.004","article-title":"Effect of diclofenac on SLC16A3\/MCT4 by the Caco-2 cell line.","volume":"31","author":"Sasaki","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11156","article-title":"Salicylate, diflunisal and their metabolites inhibit CBP\/p300 and exhibit anticancer activity.","volume":"5","author":"Shirakawa","year":"2016","journal-title":"eLife"},{"key":"B28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/srep09149","article-title":"The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.","volume":"5","author":"Tesori","year":"2015","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology.","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.embor.embor821","article-title":"Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.","volume":"4","author":"Vervoorts","year":"2003","journal-title":"EMBO Rep."},{"key":"B32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body.","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1182\/blood-2012-08-447763","article-title":"AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX\/beta-catenin signaling pathway.","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01258\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:37:59Z","timestamp":1541133479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01258\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":33,"alternative-id":["10.3389\/fphar.2018.01258"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01258","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"1258"}}